Washington, D.C. – U.S. Senators Charles E. Schumer and Kirsten Gillibrand today announced $124,541 in federal dollars to support medical training and research programs at Cornell University. The funds from the U.S. Department of Health and Human Services (HHS) will help advance medical research and treatment, as well as give student and teachers hands-on training and experience in National Institutes of Health (NIH) laboratories. The federal investments for Cornell are part of the American Recovery and Reinvestment Act, which Senators Schumer and Gillibrand helped pass earlier this year.
“Federal funding for medical research and training is needed now more than ever,” said Schumer. “In these difficult economic times, it is critical that we continue to invest in cutting-edge medical research to push the boundaries of medicine and promote long-term economic growth. I will continue to fight for federal funds that will advance Cornell University as a world-class research institution.”
“It is critical that we invest in the life-saving research and personnel training at our world class medical facilities at Cornell,” said Senator Gillibrand. “Federal funding for these cutting edge research and training programs will help with medical diagnosis and treatment while promoting economic growth for all of New York. I will continue to work with Senator Schumer to ensure that New York receives its fair share of federal dollars.”
Cornell University will receive $77,000 to advance research and treatment to combat liver diseases. Cornell will also receive $47,541 to support efforts that give students and teachers hands-on training and research experience in NIH-funded laboratories.
Senators Schumer and Gillibrand are strong supporters of President Obama’s economic plan. The investment will help create or save more than 200,000 jobs in New York, while laying the foundation of future economic growth with critical investments in health care technology and research, education, infrastructure and renewable energy.